BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15664356)

  • 1. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs 1. Simultaneous determination of quinidine and permeability markers in rat in situ perfusion samples.
    Varma MV; Sarkar M; Kapoor N; Panchagnula R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):243-9. PubMed ID: 15664356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies.
    Venkatesh G; Ramanathan S; Mansor SM; Nair NK; Sattar MA; Croft SL; Navaratnam V
    J Pharm Biomed Anal; 2007 Mar; 43(4):1546-51. PubMed ID: 17157469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of digoxin and permeability markers in rat in situ intestinal perfusion samples by RP-HPLC.
    Varma MV; Kapoor N; Sarkar M; Panchagnula R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):347-52. PubMed ID: 15556552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies.
    Panchagnula R; Bansal T; Varma MV; Kaul CL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):277-82. PubMed ID: 15171939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent determination of topotecan and model permeability markers (atenolol, antipyrine, propranolol and furosemide) by reversed phase liquid chromatography: utility in Caco-2 intestinal absorption studies.
    Bansal T; Singh M; Mishra G; Talegaonkar S; Khar RK; Jaggi M; Mukherjee R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(2):261-6. PubMed ID: 17936093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability of atenolol and propranolol in the presence of dimethyl sulfoxide in rat single-pass intestinal perfusion assay with liquid chromatography/UV detection.
    Venkatesh G; Ramanathan S; Nair NK; Mansor SM; Sattar MA; Khan MA; Navaratnam V
    Biomed Chromatogr; 2007 May; 21(5):484-90. PubMed ID: 17294505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatography method development and validation for simultaneous determination of five model compounds, antipyrine, metoprolol, ketoprofen, furosemide and phenol red, as a tool for the standardization of rat in situ intestinal permeability studies using timed wavelength detection.
    Chawla S; Ghosh S; Sihorkar V; Nellore R; Kumar TR; Srinivas NR
    Biomed Chromatogr; 2006 Apr; 20(4):349-57. PubMed ID: 16161180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of nine model compounds in permeability samples using RP-HPLC: application to prove the cassette administration principle in single pass intestinal perfusion study in rats.
    Wahajuddin ; Singh SP; Raju KS; Nafis A; Jain GK
    J Pharm Biomed Anal; 2012; 67-68():71-6. PubMed ID: 22613582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
    Panchagnula R; Bansal T; Varma MV; Kaul CL
    Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
    Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
    Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of RP-HPLC-fluorescence method for quantitative determination of quinidine, a probe substrate for P-glycoprotein inhibition assay using Caco-2 cell monolayer.
    Patil AG; Reddy D; D'Souza R; Damre A
    Biomed Chromatogr; 2010 Jun; 24(6):620-5. PubMed ID: 19816852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of isomer specific RP-HPLC method for quantification of cefpodoxime proxetil.
    Kakumanu VK; Arora VK; Bansal AK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):16-20. PubMed ID: 16517228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
    Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
    Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of kadsurenone and its interaction with cyclosporin A in rats using a combined HPLC and microdialysis system.
    Huang SP; Lin LC; Wu YT; Tsai TH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):247-52. PubMed ID: 19111511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
    Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
    González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
    Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.